{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:46:09Z","timestamp":1791902769693,"version":"4.3.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T00:00:00Z","timestamp":1703894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T00:00:00Z","timestamp":1703894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["Core Research Grant; Grant Number: CRG\/2021\/001009)"],"award-info":[{"award-number":["Core Research Grant; Grant Number: CRG\/2021\/001009)"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s11064-023-04082-9","type":"journal-article","created":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T13:01:32Z","timestamp":1703941292000},"page":"1556-1576","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Purmorphamine, a Smo-Shh\/Gli Activator, Promotes Sonic Hedgehog-Mediated Neurogenesis and Restores Behavioural and Neurochemical Deficits in Experimental Model of Multiple Sclerosis"],"prefix":"10.1007","volume":"49","author":[{"given":"Aradhana","family":"Prajapati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0034-835X","authenticated-orcid":false,"given":"Sidharth","family":"Mehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuber","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swesha","family":"Chhabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanshyam","family":"Das Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,30]]},"reference":[{"issue":"5","key":"4082_CR1","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1007\/s12640-021-00401-6","volume":"39","author":"A Singh","year":"2021","unstructured":"Singh A, Upadhayay S, Mehan S (2021) Understanding abnormal c- JNK\/p38MAPK signaling overactivation involved in the progression of multiple sclerosis: possible therapeutic targets and impact on neurodegenerative diseases. Neurotox Res 39(5):1630\u20131650","journal-title":"Neurotox Res"},{"issue":"8","key":"4082_CR2","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.3390\/genes13081324","volume":"13","author":"S Upadhayay","year":"2022","unstructured":"Upadhayay S, Mehan S, Prajapati A, Sethi P, Suri M, Zawawi A, Almashjary MN, Tabrez S (2022) Nrf2\/HO-1 signaling stimulation through acetyl-11-keto-beta-boswellic acid (AKBA) provides neuroprotection in ethidium bromide-induced experimental model of multiple sclerosis. Genes 13(8):1324. https:\/\/doi.org\/10.3390\/genes13081324","journal-title":"Genes"},{"issue":"10","key":"4082_CR3","first-page":"1935","volume":"70","author":"PA Calabresi","year":"2004","unstructured":"Calabresi PA (2004) Diagnosis and management of multiple sclerosis. Am Fam Physician 70(10):1935\u20131944","journal-title":"Am Fam Physician"},{"issue":"5","key":"4082_CR4","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1212\/01.wnl.0000201238.93586.d9","volume":"66","author":"MP Sanfilipo","year":"2006","unstructured":"Sanfilipo MP, Benedict RHB, Weinstock-Guttman B, Bakshi R (2006) Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology 66(5):685\u2013692. https:\/\/doi.org\/10.1212\/01.wnl.0000201238.93586.d9","journal-title":"Neurology"},{"issue":"10","key":"4082_CR5","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1177\/1352458516680750","volume":"23","author":"S Batista","year":"2017","unstructured":"Batista S, d\u2019Almeida OC, Afonso A, Freitas S, Mac\u00e1rio C, Sousa L et al (2017) Impairment of social cognition in multiple sclerosis: amygdala atrophy is the main predictor. Multiple Scler J 23(10):1358\u20131366","journal-title":"Multiple Scler J"},{"issue":"18","key":"4082_CR6","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.3390\/cells11182771","volume":"11","author":"T Kapoor","year":"2022","unstructured":"Kapoor T, Mehan S, Suri M, Sharma N, Kumar N, Narula AS, Alshammari A, Alasmari AF, Alharbi M, Assiri MA, Kalfin R (2022) Forskolin, an Adenylcyclase\/cAMP\/CREB signaling activator restoring myelin-associated oligodendrocyte destruction in experimental ethidium bromide model of multiple sclerosis. Cells 11(18):2771. https:\/\/doi.org\/10.3390\/cells11182771","journal-title":"Cells"},{"key":"4082_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-022-01026-0","author":"A Sharma","year":"2022","unstructured":"Sharma A, Bhalla S, Mehan S (2022) PI3K\/AKT\/mTOR signalling inhibitor chrysophanol ameliorates neurobehavioural and neurochemical defects in propionic acid-induced experimental model of autism in adult rats. Metabolic Brain Dis. https:\/\/doi.org\/10.1007\/s11011-022-01026-0","journal-title":"Metabolic Brain Dis"},{"issue":"1","key":"4082_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yfrne.2012.01.001","volume":"33","author":"M Kipp","year":"2012","unstructured":"Kipp M, Amor S, Krauth R, Beyer C (2012) Multiple sclerosis: neuroprotective alliance of estrogen-progesterone and gender. Front Neuroendocrinol 33(1):1\u201316. https:\/\/doi.org\/10.1016\/j.yfrne.2012.01.001","journal-title":"Front Neuroendocrinol"},{"issue":"3","key":"4082_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2165\/00023210-200519030-00005","volume":"19","author":"SL Galetta","year":"2005","unstructured":"Galetta SL, Markowitz C (2005) US FDA-approved disease-modifying treatments for multiple sclerosis. CNS Drugs 19(3):239\u2013252","journal-title":"CNS Drugs"},{"issue":"5","key":"4082_CR10","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1523\/JNEUROSCI.3334-12.2013","volume":"33","author":"J Ferent","year":"2013","unstructured":"Ferent J, Zimmer C, Durbec P, Ruat M, Traiffort E (2013) Sonic Hedgehog signaling is a positive oligodendrocyte regulator during demyelination. J Neurosci 33(5):1759\u20131772","journal-title":"J Neurosci"},{"issue":"1","key":"4082_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-018-0220-7","volume":"16","author":"GB Carballo","year":"2018","unstructured":"Carballo GB, Honorato JR, de Lopes GPF (2018) A highlight on sonic hedgehog pathway. Cell Commun Signal 16(1):1\u201315","journal-title":"Cell Commun Signal"},{"issue":"3","key":"4082_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ymthe.2004.05.021","volume":"10","author":"A Hurtado-Lorenzo","year":"2004","unstructured":"Hurtado-Lorenzo A, Millan E, Gonzalez-Nicolini V, Suwelack D, Castro MG, Lowenstein PR (2004) Differentiation and transcription factor gene therapy in experimental Parkinson\u2019s disease: sonic hedgehog and Gli-1, but not Nurr-1, protect nigrostriatal cell bodies from 6-OHDA-induced neurodegeneration. Mol Ther 10(3):507\u2013524","journal-title":"Mol Ther"},{"issue":"1\u20132","key":"4082_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0925-4773(01)00458-0","volume":"107","author":"AR Paganelli","year":"2001","unstructured":"Paganelli AR, Oca\u00f1a OH, Prat MI, Franco PG, L\u00f3pez SL, Morelli L et al (2001) The Alzheimer-related gene presenilin-1 facilitates sonic hedgehog expression in Xenopus primary neurogenesis. Mech Develop 107(1\u20132):119\u2013131","journal-title":"Mech Develop"},{"issue":"11","key":"4082_CR14","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1177\/09603271211013456","volume":"40","author":"S Rahi","year":"2021","unstructured":"Rahi S, Gupta R, Sharma A, Mehan S (2021) Smo-Shh signaling activator purmorphamine ameliorates neurobehavioral, molecular, and morphological alterations in an intracerebroventricular propionic acid-induced experimental model of autism. Hum Exp Toxicol 40(11):1880\u20131898","journal-title":"Hum Exp Toxicol"},{"issue":"12","key":"4082_CR15","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1007\/s11064-018-2645-1","volume":"43","author":"L Liu","year":"2018","unstructured":"Liu L, Zhao B, Xiong X, Xia Z (2018) The neuroprotective roles of sonic hedgehog signaling pathway in ischemic stroke. Neurochem Res 43(12):2199\u20132211","journal-title":"Neurochem Res"},{"issue":"3","key":"4082_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3390\/brainsci12030342","volume":"12","author":"R Gupta","year":"2022","unstructured":"Gupta R, Mehan S, Sethi P, Prajapati A, Alshammari A, Alharbi M et al (2022) Smo-Shh agonist purmorphamine prevents neurobehavioral and neurochemical defects in 8-OH-DPAT-induced experimental model of obsessive-compulsive disorder. Brain Sci 12(3):342","journal-title":"Brain Sci"},{"issue":"8","key":"4082_CR17","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.3390\/cells9081803","volume":"9","author":"L Lopez-Caraballo","year":"2020","unstructured":"Lopez-Caraballo L, Martorell-Marugan J, Carmona-S\u00e1ez P, Gonzalez-Munoz E (2020) iPS-derived early oligodendrocyte progenitor cells from SPMS patients reveal deficient in vitro cell migration stimulation. Cells 9(8):1803","journal-title":"Cells"},{"key":"4082_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.nbd.2015.01.006","volume":"76","author":"J Zhang","year":"2015","unstructured":"Zhang J, Zhang ZG, Li Y, Ding X, Shang X, Lu M et al (2015) Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis. Neurobiol Dis 76:57\u201366","journal-title":"Neurobiol Dis"},{"issue":"3","key":"4082_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s12017-019-08558-2","volume":"21","author":"E Angelopoulou","year":"2019","unstructured":"Angelopoulou E, Piperi C (2019) Beneficial effects of fingolimod in Alzheimer\u2019s disease: molecular mechanisms and therapeutic potential. NeuroMol Med 21(3):227\u2013238","journal-title":"NeuroMol Med"},{"issue":"4","key":"4082_CR20","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1007\/s13311-016-0462-2","volume":"13","author":"RL Potenza","year":"2016","unstructured":"Potenza RL, De Simone R, Armida M, Mazziotti V, P\u00e8zzola A, Popoli P, Minghetti L (2016) Fingolimod: a disease-modifier drug in a mouse model of amyotrophic lateral sclerosis. Neurotherapeutics 13(4):918\u2013927","journal-title":"Neurotherapeutics"},{"issue":"1","key":"4082_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1096\/fj.201600751r","volume":"31","author":"P Zhao","year":"2017","unstructured":"Zhao P, Yang X, Yang L, Li M, Wood K, Liu Q, Zhu X (2017) Neuroprotective effects of fingolimod in mouse models of Parkinson\u2019s disease. FASEB J 31(1):172\u2013179","journal-title":"FASEB J"},{"key":"4082_CR22","doi-asserted-by":"publisher","first-page":"577480","DOI":"10.1016\/j.jneuroim.2021.577480","volume":"352","author":"Y Chu","year":"2021","unstructured":"Chu Y, Jing Y, Zhao X, Wang M, Zhang M, Ma R, Ma W, Lv Y, Zhu L (2021) Modulation of the HMGB1\/TLR4\/NF-\u03baB signaling pathway in the CNS by matrine in experimental autoimmune encephalomyelitis. J Neuroimmunol 352:577480. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577480","journal-title":"J Neuroimmunol"},{"key":"4082_CR23","doi-asserted-by":"publisher","first-page":"134599","DOI":"10.1016\/j.neulet.2019.134599","volume":"715","author":"W Ma","year":"2020","unstructured":"Ma W, Zhang M, Liu S, Wang M, Shi Y, Yang T, Li X, Zhu L (2020) Matrine alleviates astrogliosis through sphingosine 1-phosphate signaling in experimental autoimmune encephalomyelitis. Neurosci Lett 715:134599. https:\/\/doi.org\/10.1016\/j.neulet.2019.134599","journal-title":"Neurosci Lett"},{"issue":"560","key":"4082_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.neulet.2013.12.031","volume":"7","author":"QC Kan","year":"2014","unstructured":"Kan QC, Zhang S, Xu YM, Zhang GX, Zhu L (2014) Matrine regulates glutamate-related excitotoxic factors in experimental autoimmune encephalomyelitis. Neurosci Lett 7(560):92\u201397. https:\/\/doi.org\/10.1016\/j.neulet.2013.12.031","journal-title":"Neurosci Lett"},{"issue":"5","key":"4082_CR25","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1142\/S0192415X11009317","volume":"39","author":"X Zhao","year":"2011","unstructured":"Zhao X, Kan Q, Zhu L, Zhang GX (2011) Matrine suppresses production of IL-23\/IL-17 and ameliorates experimental autoimmune encephalomyelitis. Am J Chin Med 39(5):933\u2013941. https:\/\/doi.org\/10.1142\/S0192415X11009317","journal-title":"Am J Chin Med"},{"issue":"5","key":"4082_CR26","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s11011-021-00691-x","volume":"36","author":"N Kumar","year":"2021","unstructured":"Kumar N, Sharma N, Khera R, Gupta R, Mehan S (2021) Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological alterations in rat brain. Metab Brain Dis 36(5):911\u2013925","journal-title":"Metab Brain Dis"},{"issue":"3","key":"4082_CR27","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/brainsci11030288","volume":"11","author":"A Tiwari","year":"2021","unstructured":"Tiwari A, Khera R, Rahi S, Mehan S, Makeen HA, Khormi YH et al (2021) Neuroprotective effect of \u03b1-mangostin in ameliorating propionic acid-induced experimental model of autism in Wistar rats. Brain Sciences 11(3):288","journal-title":"Brain Sciences"},{"issue":"11","key":"4082_CR28","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1007\/s11064-021-03366-2","volume":"46","author":"E Minj","year":"2021","unstructured":"Minj E, Upadhayay S, Mehan S (2021) Nrf2\/HO-1 signaling activator acetyl-11-keto-beta boswellic acid (AKBA)-mediated neuroprotection in methyl mercury-induced experimental model of ALS. Neurochem Res 46(11):2867\u20132884","journal-title":"Neurochem Res"},{"issue":"8","key":"4082_CR29","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3390\/ph15080959","volume":"15","author":"B Rajkhowa","year":"2022","unstructured":"Rajkhowa B, Mehan S, Sethi P, Prajapati A, Suri M, Kumar S, Bhalla S, Narula AS, Alshammari A, Alharbi M, Alkahtani N, Alghamdi S, Kalfin R (2022) Activating SIRT-1 signalling with the mitochondrial-CoQ10 activator solanesol improves neurobehavioral and neurochemical defects in ouabain-induced experimental model of bipolar disorder. Pharmaceuticals (Basel) 15(8):959. https:\/\/doi.org\/10.3390\/ph15080959","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"4082_CR30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4103\/ijp.IJP_11_18","volume":"50","author":"S Mehan","year":"2018","unstructured":"Mehan S, Monga V, Rani M, Dudi R, Ghimire K (2018) Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington\u2019s disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme-Q10-mediated mitochondrial dysfunction. Indian J Pharmacol 50(6):309","journal-title":"Indian J Pharmacol"},{"key":"4082_CR31","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.toxrep.2022.04.023","volume":"9","author":"R Sahu","year":"2022","unstructured":"Sahu R, Mehan S, Kumar S, Prajapati A, Alshammari A, Alharbi M et al (2022) Effect of alpha-mangostin in the prevention of behavioural and neurochemical defects in methylmercury-induced neurotoxicity in experimental rats. Toxicol Rep 9:977\u2013998","journal-title":"Toxicol Rep"},{"issue":"1","key":"4082_CR32","first-page":"177","volume":"2","author":"S Mehan","year":"2011","unstructured":"Mehan S, Verma A, Bedi KL, Sehgal V (2011) Effect of mitogen activated protein kinase inhibitor in animal model of Alzheimer\u2019s diseases. Int J Pharma Professional\u2019s Res (IJPPR) 2(1):177\u2013188","journal-title":"Int J Pharma Professional\u2019s Res (IJPPR)"},{"key":"4082_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ibror.2020.03.001","volume":"8","author":"K Rajdev","year":"2020","unstructured":"Rajdev K, Siddiqui EM, Jadaun KS, Mehan S (2020) Neuroprotective potential of solanesol in a combined model of intracerebral and intraventricular hemorrhage in rats. IBRO reports 8:101\u2013114","journal-title":"IBRO reports"},{"issue":"6","key":"4082_CR34","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.4103\/1673-5374.270316","volume":"15","author":"S Mehan","year":"2020","unstructured":"Mehan S, Rahi S, Tiwari A, Kapoor T, Rajdev K, Sharma R et al (2020) Adenylate cyclase activator Forskolin alleviates intracerebroventricular propionic acid-induced mitochondrial dysfunction of autistic rats. Neural Regen Res 15(6):1140","journal-title":"Neural Regen Res"},{"issue":"12","key":"4082_CR35","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.3390\/molecules27123878","volume":"27","author":"A Shandilya","year":"2022","unstructured":"Shandilya A, Mehan S, Kumar S, Sethi P, Narula AS, Alshammari A et al (2022) Activation of IGF-1\/GLP-1 signalling via 4-hydroxyisoleucine prevents motor neuron impairments in experimental ALS-rats exposed to methylmercury-induced neurotoxicity. Molecules 27(12):3878","journal-title":"Molecules"},{"key":"4082_CR36","doi-asserted-by":"publisher","first-page":"096032712210842","DOI":"10.1177\/09603271221084276","volume":"41","author":"RK Yadav","year":"2022","unstructured":"Yadav RK, Mehan S, Sahu R, Kumar S, Khan A, Makeen HA, Al Bratty M (2022) Protective effects of apigenin on methylmercury-induced behavioral\/neurochemical abnormalities and neurotoxicity in rats. Hum Exp Toxicol 41:09603271221084276","journal-title":"Hum Exp Toxicol"},{"issue":"2","key":"4082_CR37","first-page":"68","volume":"10","author":"R Dudi","year":"2018","unstructured":"Dudi R, Mehan S (2018) Neuroprotection of brain permeable Forskolin ameliorates behavioral, biochemical and histopatho-logical alterations in rat model of intracerebral hemorrhage. Pharmaspire 10(2):68\u201386","journal-title":"Pharmaspire"},{"issue":"6","key":"4082_CR38","first-page":"38","volume":"10","author":"MM Alam","year":"2019","unstructured":"Alam MM, Mehan S (2019) Effect of forskolin in combination with solanesol in methyl mercury induced experimental model of amyotrophic lateral sclerosis in rats. Int J Pharm Life Sci 10(6):38","journal-title":"Int J Pharm Life Sci"},{"issue":"11","key":"4082_CR39","doi-asserted-by":"publisher","first-page":"6417","DOI":"10.1016\/j.sjbs.2021.07.010","volume":"28","author":"EM Siddiqui","year":"2021","unstructured":"Siddiqui EM, Mehan S, Upadhayay S, Khan A, Halawi M, Halawi AA, Alsaffar RM (2021) Neuroprotective efficacy of 4-Hydroxyisoleucine in experimentally induced intracerebral hemorrhage. Saudi J Biol Sci 28(11):6417\u20136431","journal-title":"Saudi J Biol Sci"},{"key":"4082_CR40","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.molimm.2022.05.002","volume":"147","author":"R Razia","year":"2022","unstructured":"Razia R, Majeed F, Amin R, Mukhtar S, Mehmood K, Baig DN (2022) The analysis of dynamic gene expression patterns in peripheral blood of multiple sclerosis patients indicates possible diagnostic and prognostic biomarkers. Mol Immunol 147:147\u2013156","journal-title":"Mol Immunol"},{"key":"4082_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-022-02819-1","author":"R Khera","year":"2022","unstructured":"Khera R, Mehan S, Kumar S, Sethi P, Bhalla S, Prajapati A (2022) Role of JAK-STAT and PPAR-Gamma signalling modulators in the prevention of autism and neurological dysfunctions. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-022-02819-1","journal-title":"Mol Neurobiol"},{"key":"4082_CR42","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s11011-020-00597-0","volume":"35","author":"S Mojaverrostami","year":"2020","unstructured":"Mojaverrostami S, Pasbakhsh P, Madadi S, Nekoonam S, Zarini D, Noori L et al (2020) Calorie restriction promotes remyelination in a Cuprizone-Induced demyelination mouse model of multiple sclerosis. Metabolic Brain Dis 35:1211\u20131224","journal-title":"Metabolic Brain Dis"},{"key":"4082_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.etap.2020.103483","volume":"80","author":"PK Sahoo","year":"2020","unstructured":"Sahoo PK, Pradhan LK, Aparna S, Agarwal K, Banerjee A, Das SK (2020) Quercetin abrogates bisphenol a induced altered neurobehavioral response and oxidative stress in zebrafish by modulating brain antioxidant defence system. Environ Toxicol Pharmacol 80:103483","journal-title":"Environ Toxicol Pharmacol"},{"issue":"4","key":"4082_CR44","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s10571-020-01010-1","volume":"42","author":"S Rahi","year":"2022","unstructured":"Rahi S, Mehan S (2022) Understanding abnormal SMO-SHH signaling in autism spectrum disorder: potential drug target and therapeutic goals. Cell Mol Neurobiol 42(4):931\u2013953","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"4082_CR45","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11596-022-2496-x","volume":"42","author":"KS Jadaun","year":"2022","unstructured":"Jadaun KS, Mehan S, Sharma A, Siddiqui EM, Kumar S, Alsuhaymi N (2022) Neuroprotective effect of chrysophanol as a PI3K\/AKT\/mTOR signaling inhibitor in an experimental model of autologous blood-induced intracerebral hemorrhage. Curr Med Sci 42(2):249\u2013266. https:\/\/doi.org\/10.1007\/s11596-022-2496-x","journal-title":"Curr Med Sci"},{"issue":"22","key":"4082_CR46","doi-asserted-by":"publisher","first-page":"7951","DOI":"10.3390\/molecules27227951","volume":"27","author":"M Alharbi","year":"2022","unstructured":"Alharbi M, Alshammari A, Kaur G, Kalra S, Mehan S, Suri M, Chhabra S, Kumar N, Alanazi WA, Alshanwani AR, Al-Ghamdi AH, Narula AS, Kalfin R (2022) Effect of natural Adenylcyclase\/cAMP\/CREB signalling Activator forskolin against intra-striatal 6-OHDA-lesioned Parkinson\u2019s rats: preventing mitochondrial, motor and histopathological defects. Molecules 27(22):7951. https:\/\/doi.org\/10.3390\/molecules27227951","journal-title":"Molecules"},{"issue":"5","key":"4082_CR47","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1089\/jir.2014.0225","volume":"35","author":"PM Nguyen","year":"2015","unstructured":"Nguyen PM, Putoczki TL, Ernst M (2015) STAT3-activating cytokines: a therapeutic opportunity for inflammatory bowel disease? J Interferon Cytokine Res 35(5):340\u201350. https:\/\/doi.org\/10.1089\/jir.2014.0225","journal-title":"J Interferon Cytokine Res"},{"issue":"1","key":"4082_CR48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","volume":"87","author":"JA Smith","year":"2012","unstructured":"Smith JA, Das A, Ray SK, Banik NL (2012) Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull. 87(1):10\u201320. https:\/\/doi.org\/10.1016\/j.brainresbull.2011.10.004","journal-title":"Brain Res Bull."},{"issue":"8","key":"4082_CR49","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3390\/molecules24081583","volume":"24","author":"A Singh","year":"2019","unstructured":"Singh A, Kukreti R, Saso L, Kukreti S (2019) Oxidative stress: a key modulator in neurodegenerative diseases. Molecules (Basel, Switzerland) 24(8):1583. https:\/\/doi.org\/10.3390\/molecules24081583","journal-title":"Molecules (Basel, Switzerland)"},{"key":"4082_CR50","doi-asserted-by":"publisher","first-page":"8416763","DOI":"10.1155\/2017\/8416763","volume":"2017","author":"G Pizzino","year":"2017","unstructured":"Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, Squadrito F, Altavilla D, Bitto A (2017) Oxidative stress: harms and benefits for human health. Oxid Med Cell Longev 2017:8416763. https:\/\/doi.org\/10.1155\/2017\/8416763","journal-title":"Oxid Med Cell Longev"},{"issue":"10","key":"4082_CR51","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.3390\/antiox10101518","volume":"10","author":"D Jantas","year":"2021","unstructured":"Jantas D, Laso\u0144 W (2021) preclinical evidence for the interplay between oxidative stress and RIP1-dependent cell death in neurodegeneration: state of the art and possible therapeutic implications. Antioxidants (Basel, Switzerland) 10(10):1518. https:\/\/doi.org\/10.3390\/antiox10101518","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"4082_CR52","doi-asserted-by":"publisher","first-page":"3975101","DOI":"10.1155\/2016\/3975101","volume":"2016","author":"IM Balmus","year":"2016","unstructured":"Balmus IM, Ciobica A, Antioch I, Dobrin R, Timofte D (2016) Oxidative stress implications in the affective disorders: main biomarkers, animal models relevance, genetic perspectives, and antioxidant approaches. Oxid Med Cell Longev 2016:3975101. https:\/\/doi.org\/10.1155\/2016\/3975101","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"4082_CR53","first-page":"63","volume":"7","author":"M Goudarzvand","year":"2016","unstructured":"Goudarzvand M, Choopani S, Shams A, Javan M, Khodaii Z, Ghamsari F, Naghdi N, Piryaei A, Haghparast A (2016) Focal injection of ethidium bromide as a simple model to study cognitive deficit and its improvement. Basic and clinical neuroscience 7(1):63\u201372","journal-title":"Basic and clinical neuroscience"},{"issue":"1","key":"4082_CR54","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00726-021-03111-7","volume":"54","author":"V Martinsen","year":"2022","unstructured":"Martinsen V, Kursula P (2022) Multiple sclerosis and myelin basic protein: insights into protein disorder and disease. Amino Acids. 54(1):99\u2013109. https:\/\/doi.org\/10.1007\/s00726-021-03111-7","journal-title":"Amino Acids."},{"issue":"3","key":"4082_CR55","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/bpa.12516","volume":"28","author":"N Petrova","year":"2018","unstructured":"Petrova N, Carassiti D, Altmann DR, Baker D, Schmierer K (2018) Axonal loss in the multiple sclerosis spinal cord revisited. Brain Pathol 28(3):334\u2013348. https:\/\/doi.org\/10.1111\/bpa.12516","journal-title":"Brain Pathol"},{"issue":"1","key":"4082_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22074\/cellj.2016.4867","volume":"19","author":"N Ghasemi","year":"2017","unstructured":"Ghasemi N, Razavi S, Nikzad E (2017) Multiple sclerosis: pathogenesis, symptoms diagnoses and cell-based therapy. Cell J 19(1):1\u201310. https:\/\/doi.org\/10.22074\/cellj.2016.4867","journal-title":"Cell J"},{"key":"4082_CR57","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fphar.2020.00204","volume":"11","author":"D Liu","year":"2020","unstructured":"Liu D, Bai X, Ma W, Xin D, Chu X, Yuan H, Qiu J, Ke H, Yin S, Chen W, Wang Z (2020) Purmorphamine attenuates neuro-inflammation and synaptic impairments after hypoxic-ischemic injury in neonatal mice via Shh signaling. Front Pharmacol 11:204. https:\/\/doi.org\/10.3389\/fphar.2020.00204","journal-title":"Front Pharmacol"},{"issue":"15","key":"4082_CR58","doi-asserted-by":"publisher","first-page":"e1324","DOI":"10.1212\/WNL.0000000000005292","volume":"90","author":"L Gaetano","year":"2018","unstructured":"Gaetano L, H\u00e4ring DA, Radue EW, Mueller-Lenke N, Thakur A, Tomic D, Kappos L, Sprenger T (2018) Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis. Neurology 90(15):e1324\u2013e1332. https:\/\/doi.org\/10.1212\/WNL.0000000000005292","journal-title":"Neurology"},{"issue":"4","key":"4082_CR59","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s40263-017-0415-2","volume":"31","author":"N De Stefano","year":"2017","unstructured":"De Stefano N, Silva DG, Barnett MH (2017) Effect of fingolimod on brain volume loss in patients with multiple sclerosis. CNS Drugs 31(4):289\u2013305. https:\/\/doi.org\/10.1007\/s40263-017-0415-2","journal-title":"CNS Drugs"},{"issue":"4","key":"4082_CR60","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10522-023-10034-1","volume":"24","author":"A Prajapati","year":"2023","unstructured":"Prajapati A, Mehan S, Khan Z (2023) The role of Smo-Shh\/Gli signaling activation in the prevention of neurological and ageing disorders. Biogerontology 24(4):493\u2013531. https:\/\/doi.org\/10.1007\/s10522-023-10034-1","journal-title":"Biogerontology"},{"issue":"1","key":"4082_CR61","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10571-018-0632-3","volume":"39","author":"MO Klein","year":"2019","unstructured":"Klein MO, Battagello DS, Cardoso AR, Hauser DN, Bittencourt JC, Correa RG (2019) Dopamine: functions, signaling, and association with neurological diseases. Cell Mol Neurobiol 39(1):31\u201359. https:\/\/doi.org\/10.1007\/s10571-018-0632-3","journal-title":"Cell Mol Neurobiol"},{"issue":"13","key":"4082_CR62","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.3390\/jcm12134274","volume":"12","author":"Z Khan","year":"2023","unstructured":"Khan Z, Gupta GD, Mehan S (2023) Cellular and molecular evidence of multiple sclerosis diagnosis and treatment challenges. J Clin Med 12(13):4274. https:\/\/doi.org\/10.3390\/jcm12134274","journal-title":"J Clin Med"},{"key":"4082_CR63","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neuro.2023.08.001","volume":"98","author":"P Sethi","year":"2023","unstructured":"Sethi P, Mehan S, Khan Z, Chhabra S (2023) Acetyl-11-keto-beta boswellic acid(AKBA) modulates CSTC-pathway by activating SIRT-1\/Nrf2-HO-1 signalling in experimental rat model of obsessive-compulsive disorder: evidenced by CSF, blood plasma and histopathological alterations. Neurotoxicology 98:61\u201385. https:\/\/doi.org\/10.1016\/j.neuro.2023.08.001","journal-title":"Neurotoxicology"},{"key":"4082_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2023.578200","author":"S Chhabra","year":"2023","unstructured":"Chhabra S, Mehan S, Khan Z, Gupta GD, Narula AS (2023) Matrine mediated neuroprotective potential in experimental multiple sclerosis: evidence from CSF, blood markers, brain samples and in-silico investigations. J Neuroimmunol. https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578200","journal-title":"J Neuroimmunol"},{"issue":"4","key":"4082_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2021.100051","volume":"1","author":"N Sharma","year":"2021","unstructured":"Sharma N, Upadhayay S, Shandilya A, Sahu R, Singh A, Rajkhowa B, Mehan S (2021) Neuroprotection by solanesol against ethidium bromide-induced multiple sclerosis-like neurobehavioral, molecular, and neurochemical alterations in experimental rats. Phytomedicine plus 1(4):100051","journal-title":"Phytomedicine plus"},{"issue":"2","key":"4082_CR66","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1309\/AJCPCYCH96QYPHJM","volume":"138","author":"DN Greene","year":"2012","unstructured":"Greene DN, Schmidt RL, Wilson AR, Freedman MS, Grenache DG (2012) Cerebrospinal fluid myelin basic protein is frequently ordered but has little value: a test utilization study. Am J Clin Pathol 138(2):262\u2013272. https:\/\/doi.org\/10.1309\/AJCPCYCH96QYPHJM","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"4082_CR67","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5114\/ceji.2020.94682","volume":"45","author":"B Polis","year":"2020","unstructured":"Polis B, Polis L, Zeman K, Pa\u015bnik J, Nowos\u0142awska E (2020) CSF levels of myelin basic protein in pediatric patients with ventriculoperitoneal shunt infection. Central-European J Immunol 45(1):48\u201355. https:\/\/doi.org\/10.5114\/ceji.2020.94682","journal-title":"Central-European J Immunol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-023-04082-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-023-04082-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-023-04082-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T05:11:00Z","timestamp":1716181860000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-023-04082-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,30]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["4082"],"URL":"https:\/\/doi.org\/10.1007\/s11064-023-04082-9","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,30]]},"assertion":[{"value":"18 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted according to the guidelines of the Institutional Animal Ethics Committee (IAEC) with a registration number. 816\/PO\/ReBiBt\/S\/04\/CPCSEA as protocol no. ISFCP\/IAEC\/CPCSEA\/Meeting No: 30\/2021\/Protocol No. 494 approved by RAB Committee, ISFCP, Moga, Punjab, India.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}